Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10550386
Monomers and oligonucleotides comprising cycloaddition adduct(s)
granted -
US 10548879
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
granted -
US 10548970
Human rotavirus G9P[6] strain and use as a vaccine
granted -
US 10548302
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
granted -
US 10548964
Antigens and vaccines directed against human enteroviruses
granted -
US 10548883
Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor
granted -
US 10550407
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10548890
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 10550156
Ang (1-7) derivative oligopeptides and methods for using and producing the same
granted -
US 10553318
Individual and cohort pharmacological phenotype prediction platform
granted -
US 10548860
HIF-1 modulator paint formulation and uses thereof
granted -
US 10548987
Antibody-drug conjugates for targeting CD56-positive tumors
granted -
US 10548971
MERS-CoV vaccine
granted -
US 10550390
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 10550391
Organic compositions to treat beta-ENaC-related diseases
granted -
US 10550195
Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
granted -
US 10550193
Methods and antibody compositions for tumor treatment
granted -
US 10550192
Antigen-binding proteins that antagonize leptin receptor
granted -
US 10550157
Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
granted -
US 10550163
Peptide fragments of netrin-1 and compositions and methods thereof
granted -
US 10550085
Deuterated compounds and uses thereof
granted -
US 10548984
RVG Derived peptides
granted -
US 10550118
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10548979
Light-activated compositions and methods using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.